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The Loss of MCP-1 Attenuates Cutaneous
Ischemia–Reperfusion Injury in a Mouse Model
of Pressure Ulcer
Yuki Saito1, Minoru Hasegawa1, Manabu Fujimoto1, Takashi Matsushita1, Mayuka Horikawa1,
Motoi Takenaka2, Fumihide Ogawa2, Junko Sugama3, Douglas A. Steeber4, Shinichi Sato2 and
Kazuhiko Takehara1
The formation of pressure ulcers is dependent on multiple factors including ischemia–reperfusion (IR). This
study assessed the mechanism of a previously reported murine model of cutaneous IR injury. Three cycles of IR
(days 1–3) by external application of two magnetic plates were performed to induce pressure ulcer formation.
Increased infiltration of neutrophils and macrophages, and augmented expression of proinflammatory
cytokines and inducible nitric oxide synthase (iNOS), were observed during IR cycles. In this model, monocyte
chemoattractant protein-1 (MCP-1) was remarkably increased at day 1 in the skin followed by inflammatory cell
infiltration. Therefore, IR cycles were performed in MCP-1-deficient (MCP-1/) mice to evaluate the role of this
chemokine in pressure ulcer development. MCP-1/ mice showed reduced macrophage infiltration and
expression of tumor-necrosis factor-a (TNF)-a and iNOS during IR cycles leading to attenuated apoptosis and
skin injury. Importantly, MCP-1 played a role in apoptosis and injury via inducing iNOS during the reperfusion
rather than the ischemic period. These findings indicate that MCP-1 may be a critical factor for macrophage
recruitment and subsequent skin inflammation and injury during IR cycles. We propose that this is a useful
model for investigating the mechanism of pressure ulcer formation using various transgenic mice.
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INTRODUCTION
Chronic pressure ulcers have become a much larger clinical
problem due to the increasing population of senior citizens
around the world. Although the etiology of pressure ulcers is
multifactorial and remains unclear, tissue ischemia has long
been considered the main factor (Kosiak, 1959; Daniel
et al., 1981). However, increasing evidence demonstrates a
principal role of ischemia–reperfusion (IR) in the formation of
chronic skin wounds, including pressure ulcers (Salcido
et al., 1994; Peirce et al., 2000) as well as other organs
(Quinones-Baldrich and Caswell, 1991; Kubes, 1995). None-
theless, limitations of current animal models of pressure
ulcers have made it difficult to clarify the underlying
mechanism of their formation. Peirce et al. (2000) created
an excellent reproducible pressure ulcer model by surgically
implanting a stainless-steel plate in the dorsal rat skin and
using cyclical magnet compression. In their study, repeated
IR cycles were more damaging to skin tissues than prolonged
ischemia alone, suggesting that the reperfusion phase of the
IR cycle was crucial for skin injury. However, this model
requires a surgical procedure to initiate the process and
leaves a foreign material under the wound. Although a similar
model was also generated in the mouse (Reid et al., 2004), it
had the same problems. Tsuji et al. (2005) established a novel
cutaneous IR injury model using their original skin fold
chamber. Under their system, the microcirculatory response
following IR injury can be visualized. However, this system is
not simple and requires immobilization of mice during
the compression treatments. Recently, Stadler et al.
(2004) has reported a very simple, reproducible, and
noninvasive IR model using the external application of two
round magnetic plates without long-term immobilization of
the mice. However, the precise clinical or histopathological
course and the mechanism of pressure ulcer formation
in this model remain unknown. This may be one reason
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why reports using this model have not been published
thus far.
IR injury has been defined as cellular injury resulting from
blood reperfusion to previously ischemic sites (McCord,
1985; Pretto, 1991; Grace, 1994; Woolfson et al., 1994;
Kubes, 1995). IR induces more severe tissue injury compared
with ischemia alone (Parks and Granger, 1986). It is thought
that ischemic tissue reduces its metabolism to preserve
function. However, subsequent reperfusion of blood to the
nutrient- and oxygen-depleted tissue can initiate a series of
harmful events due to an increase in oxygen-derived free
radicals, which exceed the capacity of the normal free-
radical-scavenging mechanisms. Free radical oxidative injury
can cause inflammation and severe derangement of the cell
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Figure 1. Short-term changes in skin tissue and inflammation during IR cycles. (a) Representative photographs of wounds during IR cycles (days 0–3) in wild-
type mice. Macroscopic ulcer was unclear during this period. (b) Representative histological tissue sections (hematoxylin and eosin staining) showing edema,
inflammatory cell infiltration, and necrotic change in the wounded area (original magnification 12.5). Red arrowheads indicate the edge of the wounds treated
with IR cycles. The areas magnified in (c) and (d) are indicated by the letter ‘‘c’’ and ‘‘d’’ in (b). (c) Higher magnification of epidermis and dermis at the wound
edge (original magnification  200). (d) Higher magnification of hypodermis at the central part of the wound bed (original magnification  100). (e) IR cycle-
induced recruitment of neutrophils and macrophages in the skin. Numbers of neutrophils and macrophages per section were determined by counting
myeloperoxidase- and F4/80-stained skin sections, respectively. Eight of HPFs (0.07mm2) in five serial sections were counted and averaged. All values represent
the mean±SEM of results obtained from more than six mice for each time point of examination. Representative histological tissue sections showing the
infiltration of neutrophils and macrophages are also shown (original magnifications 200).
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recruitment process to the site of injury (Robson et al., 2000).
Furthermore, altered endothelial cell function can limit
cytokine production and delay wound healing (Robson
et al., 2000). Nitric oxide (NO) is one such free radical and
excessive NO or its synthase, inducible NO synthase (iNOS),
is considered to play pathogenic roles in IR-induced
apoptosis and tissue injury of some organs, including skin,
myocardium, and kidney (Lipton et al., 1993; Nathan and
Xie, 1994; Kubes, 2000; Furuichi et al., 2003; Reid et al.,
2004; Schulz et al., 2004; Hayasaki et al., 2006).
Leukocytic infiltration plays a crucial role in IR injury,
such as cerebrovascular accident, myocardial ischemia, and
ischemic renal injury. Chemokines are small heparin-binding
proteins that direct the migration of circulating leukocytes to
sites of injury or inflammation (Gerard and Rollins, 2001;
Rot and von Andrian, 2004). The prototypical CC chemokine
is monocyte chemoattractant protein-1 (MCP-1/CCL2), a key
molecule for chemotaxis and activation of macrophages
(Matsushima et al., 1989; Leonard and Yoshimura, 1990).
MCP-1 is secreted by various cell types such as macrophages,
T lymphocytes, endothelial cells, epidermal cells, and
fibroblasts. MCP-1 and its receptor, CC chemokine receptor 2
(CCR2), have been shown to contribute to IR injury of some
organs, including myocardium and the kidney (Furuichi
et al., 2003; Hayasaki et al., 2006). Other members of the CC
family include macrophage inflammatory protein-1a (MIP-
1a/CCL3), MIP-1b/CCL4, and RANTES/CCL5. The main
members of the CXC chemokines that can attract and activate
neutrophils are keratinocyte-derived chemokine (KC/CXCL1)
and MIP-2/CXCL2 in mice. The third family, the CX3C family,
has only one known member, fractalkine/CX3CL1. In soluble
form, fractalkine is a potent chemoattractant for CX3CR1-
expressing macrophages, T cells, and natural killer cells (Imai
et al., 1997). Importantly, in an incisional skin wound healing
model, MCP-1 and MIP-1a are found in high levels in the
early phase (Fahey et al., 1990; DiPietro et al., 1995).
Furthermore, MCP-1-deficient (MCP-1/), but not MIP-1a/
mice, display significantly delayed wound repair in the early
phase of healing, although the ultimate endpoints are similar
to that of wild-type mice (Low et al., 2001). However, the
direct role of MCP-1 or other chemokines remains unknown
in the pathogenesis of IR injury in the skin.
In this study, we investigated the precise features and
mechanism of IR injury, using the mouse pressure ulcer
model reported by Stadler et al. (2004). Our findings suggest
that recruitment of macrophages and subsequent release of
proinflammatory cytokines and toxic oxygen-derived free
radicals induce the apoptosis of skin fibroblasts and skin
injury during IR cycles. Furthermore, using this model in
MCP-1/ mice demonstrated that MCP-1 may play a critical
role in this process.
RESULTS
Macroscopic and histological findings during IR cycles
A total of 120 wild-type mice were treated with magnetic
plates. Among these, magnets dislodged in only one mouse
(0.8%) during the treatment. The mice were observed to
be quite active and did not appear to be hindered by
the additional weight. Macroscopic skin ulcers were not
apparent during IR cycles (days 1–3), although faint depres-
sions were observed after day 2 (Figure 1a). Histopatho-
logically, marked edema was found with sparse inflammatory
cell infiltration in the hypodermis after the first IR cycle
(day 1; Figures 1b–d). After 2 IR cycles, reduced edema,
dense inflammatory cell infiltration, and early signs of
necrosis of the epidermis, dermis and a part of the
hypodermis were observed. Reduced edema and inflamma-
tory cell infiltration were found after 3 IR cycles (day 3). Thus,
remarkable edema and inflammatory cell infiltration peaked
at days 1 and 2, respectively, leading to necrosis of the
skin during IR cycles.
Infiltrating neutrophils and macrophages during IR cycles
We assessed the types of leukocytes that were infiltrating the
skin during IR cycles. Specially, numbers of infiltrated
neutrophils in the hypodermis were assessed in the wound
tissues by immunohistochemical analysis using anti-myelo-
peroxidase mAb (Figure 1e). At day 1, neutrophil numbers
were significantly increased compared with control tissue
(Po0.0001). However, neutrophil numbers were further
increased at day 2 (Po0.0001 vs day 1). Although neutrophil
numbers were slightly decreased at day 3, the number was
still higher compared with that at day 1 (Po0.01). Macro-
phage infiltration was assessed by immunohistochemistry
using the F4/80 mAb (Figure 1e). Macrophage numbers
rapidly increased at days 1 and 2 compared with control
tissues (Po0.0001). Although the number of macrophages
was reduced at day 3 compared with that at days 1 and 2
(Po0.01 and Po0.001, respectively), it was still higher than
control tissues (Po0.001). In contrast to neutrophils and
macrophages, CD3þ T-cell infiltration was sparse during IR
injury (data not shown). Thus, the kinetics of neutrophil and
macrophage infiltration showed a peak at day 2 during IR
cycles.
Figure 2. Long-term changes in skin tissue and inflammation after IR cycles. (a) Representative photographs of wounds after IR cycles in wild-type mice.
Macroscopic skin ulcers became apparent at day 6, followed by a progressive reduction in size. (b) Representative histological tissue sections showing the
formation of ulcer and granulation tissue after IR cycles (original magnification  12.5). The distance between red arrowheads indicates the epithelial gap that is
the distance between the migrating edges of keratinocytes under the eschar. In (b), the areas magnified in (c) and (d) are indicated by the letter ‘‘c’’ and ‘‘d’’,
respectively. (c) Higher magnification of epidermis and dermis at the wound edge (original magnification  200). (d) Higher magnification of hypodermis at the
central part of the wound bed (original magnification  100). (e) Time course of macroscopic ulcer size in wild-type mice. The skin ulcers were healed by day
20 in all mice. (f) Time course of microscopic ulcer size was assessed as the epithelial gap. (g) Numbers of neutrophils and macrophages per HPF were
determined by counting myeloperoxidase- and F4/80-stained skin sections, respectively. Eight of HPFs in five serial sections were counted and averaged for each
time point. All values represent the mean±SEM of results obtained from more than six mice for each time point of examination. Representative histological
tissue sections showing inflammatory cell infiltration are also shown (original magnification 200).
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Formation and healing of skin ulcer after IR cycles
Macroscopic skin ulcers with thick eschar became apparent 3
days following the IR cycles (day 6; Figure 2a). From this
point on, the size of the macroscopic skin ulcer gradually
decreased and was completely healed by day 20 in all mice
(Figures 2a and e). Histological wound closure was also
analyzed since the attached eschar makes the wound size
unclear. Specifically, migration of keratinocytes under the
eschar was assessed by microscopically measuring the
epithelial gap that is the distance between the migrating
edges of keratinocytes. An epithelial gap became apparent at
day 4 and disappeared by day 18 in all mice (Figures 2b, c,
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and f). Histopathologically, the epidermis, dermis, pannicu-
lus carnosus, and a part of the hypodermis showed necrotic
change with modest inflammatory cell infiltration at day 6
(Figures 2b–d). The depth of the skin ulcer was greatest
around day 6 or 8. At day 8, granulation tissue formation
developed and this finding was more prominent at day 10.
Thus, peak size of the macroscopic or microscopic skin ulcer
was around days 4–6 after the start of IR cycles.
Infiltrating neutrophils and macrophages after IR cycles
While infiltrating neutrophils and macrophages were most
remarkable at day 2 (Figure 1e), the numbers of these
leukocytes reduced gradually until day 10 (Figure 2g). By
contrast, fibroblasts, identified by their morphological char-
acteristics, and newly formed capillaries were increased in
association with increased granulation tissue formation
during this process (Figure 2d).
mRNA expression of iNOS and proinflammatory cytokines
during IR cycles
Since iNOS is important for tissue injury during IR injury,
mRNA expression levels of iNOS were assessed by real-time
reverse transcription-PCR (RT-PCR) in the skin during IR
cycles. Relative levels of iNOS mRNA were progressively
increased by IR cycles until day 3 (Figure 3a). Since
proinflammatory cytokines may also have roles in the
development of IR-induced skin injury, mRNA expression
of IL-1b, IL-6, IFN-g, and tumor-necrosis factor (TNF)-a was
assessed in the wounded skin (Figure 3b). The relative mRNA
expression of IL-1b and IL-6 were highest at day 1, and then
gradually decreased during subsequent IR cycles. By contrast,
mRNA expression of TNF-a was highest at day 2 during IR
cycles. However, mRNA expression of IFN-g was not
detected in the skin during any of the IR cycles (data not
shown). Thus, augmented expression of some proinflamma-
tory cytokines and iNOS were found during the process of
IR-induced skin injury.
Production of chemokines during IR cycles
Leukocyte infiltration and subsequent production of cytokines
and iNOS are likely critical for IR-induced skin injury.
Therefore, protein levels of chemokines known to be critical
for leukocyte recruitment (MCP-1 and MIP-1a for macro-
phages and T cells; fractalkine for macrophages and natural
killer cells; KC for neutrophils) were measured in supernatants
from homogenized wounded skin by enzyme-linked immu-
nosorbent assay (Figure 3c). Protein levels of MCP-1 were
remarkably increased, with peak levels being found at day 1
during IR cycles. Additionally, protein levels of KC were
significantly elevated during all IR cycles. However, the levels
of MIP-1a and fractalkine were not significantly increased
during IR cycles. Thus, production of MCP-1 and KC was
significantly increased in the compressed skin during IR cycles.
MCP-1 deficiency reduced the IR cycle-induced skin injury
In general, macrophages, rather than neutrophils, are more
likely to be the major source of iNOS or proinflammatory
cytokines such as IL-1b, IL-6, and TNF-a. In addition, MCP-1
is critical for the recruitment and activation of macrophages,
and MCP-1 production was increased early during IR cycles
(Figure 3c). Therefore, we assessed the role of MCP-1 in
IR-induced skin injury using MCP-1/ mice. Since the
quantitative evaluation of skin necrosis was difficult during IR
cycles, the degree of tissue damage was estimated by
assessing wound healing. Macroscopic skin ulcers were
detected in MCP-1/ mice at day 6, and the size of the ulcer
was comparable with that of wild-type mice (Figures 4a,
5a and e). However, wound closure was significantly
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Figure 3. Expression or production of iNOS, cytokines, and chemokines during IR cycles. mRNA expression of (a) iNOS, (b) TNF-a, IL-1b, and IL-6 in skin
wounds of wild-type mice. Relative mRNA expression was quantified by real-time RT-PCR. (c) Protein levels of MCP-1, MIP-1a, KC, and fractalkine were
measured in supernatants of wounded skin homogenates by ELISA. The data were expressed as cytokine or growth factor (pgml1 or ngml1)/total protein
(mgml1) for each sample. All values represent the mean±SEM. Significant differences between sample means are indicated, *Po0.05; **Po0.01. These
results were obtained from six mice for each time point of examination.
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accelerated in the absence of MCP-1, leading to complete
healing by day 16 in all mice (Figures 5a and e). The
accelerated wound closure was also confirmed by measuring
the epithelial gap in these mice (Figures 5b, c, and f).
Specifically, the epithelial gap disappeared 4 days earlier in
MCP-1/ mice than in wild-type mice (Figure 5f). To clarify
whether this was due to reduced tissue injury or improved
wound healing in MCP-1/ mice, repair of incisional
wounds of the same size was examined in MCP-1/ mice.
However, MCP-1/ mice showed delayed incisional wound
healing compared with wild-type mice, as previously
reported (data not shown and Low et al., 2001). Furthermore,
we also assessed skin wound healing following a single
ischemic treatment of 36 hours in both wild-type and MCP-
1/ mice (Figures 5h and i). In wild-type mice, skin ulcers
due to this treatment were repaired at least 4 days earlier than
d
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Figure 4. Skin injury during IR cycles in MCP-1/mice. (a) Representative photographs of wounds during IR cycles (days 0–3) in MCP-1/mice. Macroscopic
ulcer was unclear during this period. (b) Representative histological tissue sections (hematoxylin and eosin staining) showing edema, inflammatory cell
infiltration, and necrotic change in the wounded area (original magnification  12.5). Red arrowheads indicate the edge of the wounds treated with IR cycles.
The areas magnified in (c) and (d) are indicated by the letter ‘‘c’’ and ‘‘d’’, respectively, in (b). (c) Higher magnification of epidermis and dermis at the
wound edge (original magnification  200). (d) Higher magnification of hypodermis at the central part of the wound bed (original magnification 100).
(e) IR cycle-induced recruitment of neutrophils and macrophages in the skin of MCP-1/ mice. Numbers of neutrophils and macrophages per HPF were
determined by counting myeloperoxidase- and F4/80-stained skin sections, respectively. Eight HPFs in five serial sections were counted and averaged. All values
represent the mean±SEM of results obtained from more than six mice for each time point of examination. Representative histological tissue sections showing the
infiltration of neutrophils and macrophages are also shown for each time point (original magnifications  200).
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IR cycle-induced skin ulcers despite the same total ischemic
time (total repair period, 8–10 days vs 14 days, respectively;
Figures 5e, f, h, and i). However, the total period of wound
closure was similar in both treatments of MCP-1/ mice
(8–10 days; Figures 5e, f, h, and i). These findings indicate
that MCP-1 deficiency improves wound closure by reducing
reperfusion-induced injury rather than ischemia-induced
injury or affecting wound healing. Consistent with this, the
kinetics of wound closure was comparable after a single
ischemic treatment of 36 hours in wild-type and MCP-1/
mice (Figures 5h and i). Therefore, our findings indicate that
IR tissue injury was reduced especially during the reperfusion
process but not the ischemic process by the loss of MCP-1.
MCP-1 deficiency reduced macrophage infiltration
MCP-1/ mice showed reduced numbers of skin-infiltrating
cells during and following IR cycles, compared with wild-
type mice (Figures 4d and 5d). Specifically, the numbers of
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Figure 5. Skin changes following IR cycles in MCP-1/ mice. (a) Representative photographs of wounds after IR cycles in MCP-1/ mice. Macroscopic skin
ulcers became apparent at day 6, followed by a progressive reduction in size. (b) Representative histological tissue sections showing the formation of ulcer and
granulation tissue after IR cycles (original magnification  12.5). In (b), the areas magnified in (c) and (d) are indicated by the letter ‘‘c’’ and ‘‘d’’, respectively.
(c) Higher magnification of epidermis and dermis at the wound edge (original magnification  200). (d) Higher magnification of hypodermis at the central
part of the wound bed (original magnification  100). (e) Time course of macroscopic ulcer size in MCP-1/mice. The skin ulcers were healed by day 16 in all
MCP-1/ mice. (f) Time course of epithelial gap during skin wound healing. (g) Numbers of neutrophils and macrophages per HPF were determined by
counting myeloperoxidase- and F4/80-stained skin sections, respectively. Eight HPFs in five serial sections were counted and averaged. Representative
histological tissue sections showing inflammatory cell infiltration are also shown (original magnification  200). (h) Time course of macroscopic ulcer size in
wild-type and MCP-1/ mice following a treatment with 36 hours of ischemia. (i) Time course of epithelial gap size in wild-type and MCP-1/ mice following
a treatment with 36 hours of ischemia. All values represent the mean±SEM of results obtained from more than six mice for each time point of examination in
each genotype. Significant differences between sample means are indicated, *Po0.05; **Po0.01.
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infiltrating macrophages but not neutrophils were signifi-
cantly reduced in MCP-1/ mice compared with wild-type
mice during and following IR cycles (Figures 4e and 5g).
Thus, MCP-1 is likely critical for macrophage infiltration in
IR-induced skin injury and subsequent wound healing.
MCP-1 deficiency inhibited the expression of iNOS and
proinflammatory cytokines
The role of MCP-1 in the expression of iNOS and
proinflammatory cytokines was examined in the skin of
MCP-1/ mice treated with IR cycles. mRNA expression of
iNOS was significantly inhibited in MCP-1/ mice com-
pared with wild-type mice at days 2 and 3 (Figure 6a).
Similarly, the mRNA expression of TNF-a was significantly
reduced in the lesional skin from MCP-1/ mice compared
with wild-type mice during IR cycles at day 2 (Figure 6a). By
contrast, mRNA levels of IL-1b and IL-6 were not significantly
changed by the loss of MCP-1 (Figure 6a). Thus, the loss of
MCP-1 inhibited the expression of iNOS and TNF-a in the
skin during IR cycles.
Circulating protein levels of TNF-a and MCP-1 during IR cycles
Serum levels of TNF-a and MCP-1 during IR cycles were
assessed in wild-type and MCP-1/ mice (Figure 6b). Serum
TNF-a levels were not significantly changed during IR cycles
in wild-type mice. Additionally, serum TNF-a levels in MCP-
1/ mice were comparable with that in wild-type mice.
Similarly, serum MCP-1 levels were not significantly changed
during IR cycles in wild-type mice. Thus, lesional but not
circulating TNF-a and MCP-1 are likely important for IR-
induced skin injury.
MCP-1 deficiency did not affect the expression of HIF-1a and
HSP90
Cytoprotective factors such as hypoxia-induced factors (HIFs)
and heat-shock proteins (HSPs) are known to function during
ischemic condition. HIF-1a is a heterodimeric transcription
factor consisting of HIF-1a and HIF-1b (Jiang et al., 1996).
HIF-1a protein is ubiquitinated and degraded in normoxia,
but stabilized in hypoxia and upregulates genes that promote
survival (Huang et al., 1998; Kallio et al., 1999). Additionally,
it has been demonstrated that several HSPs, including HSP90,
have antiapoptotic roles in IR-induced tissue injury (Shen
et al., 2007; Sisco et al., 2007). Therefore, the formation of IR
cycle-dependent skin injury may be the result of an IR cycle-
related decrease of cytoprotective genes. Furthermore,
inhibited skin injury in MCP-1/ mice could be due to
increased expression of cytoprotective genes. Therefore, we
assessed the gene expression of HIF-1a and HSP90 during IR
cycles in wild-type and MCP-1/ mice (Figure 6c). Although
HIF-1a expression tended to decrease during IR cycles in
wild-type mice, this was not significant. By contrast, HSP90
expression gradually increased during IR cycles in wild-type
mice, although it did not reach statistical significance. The
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loss of MCP-1 did not significantly affect the expression levels
of either of these genes. Thus, cycle-dependent skin injury
and suppressed skin injury in MCP-1/ mice are not
explained by the changes in the expression levels of HIF-1a
and HSP90.
Apoptosis during IR cycles
Nuclei of apoptotic cells were clearly identified in skin
sections using the terminal deoxynucleotidyl transferase-
mediated dUTP nick-end-labeling (TUNEL) assay. The
number of fibroblastic apoptotic cells was determined by
counting the number of TUNEL-positive cells that had the
characteristic microscopic appearance of fibroblasts. The
number of apoptotic cells in the hypodermis of the central
part of the wound bed during IR cycles was increased
depending on the number of cycles (Figures 7a and b).
However, the number of apoptotic cells was significantly
reduced during IR cycles in MCP-1/ mice compared with
wild-type mice at day 3 (Po0.01). Skin tissue from wild-type
mice that had been subjected to ischemia for 36 hours
without any reperfusion (immediately harvested after
36 hours of ischemia) showed significantly decreased apop-
totic cells compared with the usual three cycles of IR
treatment in spite of the same ischemic period (Figure 7c,
Po0.01). Both wild-type mice and MCP-1/ mice treated
with 36 hours of ischemia showed modest levels of apoptosis
that was similar with that of MCP-1/ mice treated with IR
cycles (Figure 7c). Thus, reperfusion rather than ischemia is
likely important for MCP-1-dependent apoptosis induction.
iNOS blockade attenuated IR cycle-induced apoptosis
Treatment with N-(3-aminomethyl) benzylacetamidine
(1400W), a selective iNOS inhibitor, significantly
reduced the number of IR-induced apoptotic cells at day 3
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in wild-type mice (Figure 7c, Po0.01). By contrast, 1400W
did not significantly affect IR-induced apoptosis in MCP-1/
mice, reflecting the role of MCP-1 in iNOS induction.
Additionally, iNOS inhibition did not change the number of
apoptotic cells following 36 hours ischemia in either wild-
type or MCP-1/ mice, indicating that iNOS function in
apoptosis induction is especially important in the reperfusion
period. Thus, MCP-1 likely has a role in apoptosis induction
via iNOS expression during the reperfusion period of IR
cycles.
DISCUSSION
In this study, we examined the precise process and
mechanism of a reproducible murine model of cutaneous
IR injury by the external application of magnets. Infiltration of
macrophages and neutrophils was increased in the treated
sites, with peak infiltration occurring at day 2 during IR cycles
(Figure 1e). Proinflammatory cytokines such as TNF-a, IL-1b,
and IL-6 were also increased in the skin showing peak
expression at day 1 or 2 (Figure 3b). iNOS expression
progressively increased until day 3, in parallel with the
increase in apoptotic cells (Figures 3a and 7b). Therefore, IR-
induced apoptosis and skin injury can be induced by
inflammatory cell infiltration in cooperation with proinflam-
matory cytokine production and iNOS. Importantly, protein
levels of MCP-1 were remarkably increased at day 1 in the
skin, followed by inflammatory cell infiltration (Figure 3c),
reflecting the role of this chemokine in initiating the IR injury.
Consistent with this, MCP-1/ mice showed milder skin
inflammation and injury during and following IR cycles
(Figures 4 and 5). Skin expression of TNF-a and iNOS were
also significantly reduced by the loss of MCP-1 (Figure 6a).
Importantly, MCP-1 was found to be critical for apoptosis
induction and skin injury during the reperfusion process
rather than the ischemic period (Figure 7c). Furthermore,
iNOS-blocking studies clarified the functional role of iNOS in
this process (Figure 7c). These findings indicate that MCP-1
plays a critical role in the development of IR-induced skin
injury.
We first assessed the macroscopic and histopathological
changes that occurred during and following IR cycles in this
model. Macroscopically, the formation of skin ulcers was
found at day 6 and these were repaired by day 20 in all mice
(Figures 1a, 2a and e). However, in the original report of this
model, skin ulcers were not completely repaired in all mice at
day 21 (Stadler et al., 2004). Accelerated wound repair in our
study may be due to the mouse background (C57BL/6) and
the environment (specific pathogen-free barrier facility) that
are different from the original report (BALB/c and controlled
environment, respectively). Histopathologically, skin edema
and inflammatory cell infiltration showed peak responses at
days 1 and 2, respectively (Figures 1b–d). Interestingly, skin
edema and inflammatory cell infiltration consisting primarily
of neutrophils and macrophages were reduced after three IR
cycles (day 3) compared with reduction after two IR cycles
(day 2; Figures 1b–e). Proinflammatory cytokines such as
TNF-a, IL-1b, and IL-6 were significantly increased during the
early stage (days 1–2) of the IR cycles (Figure 3b), in parallel
with the inflammatory cell infiltration. Since these proin-
flammatory cytokines are primarily produced by macro-
phages, these effecter molecules produced by infiltrated
macrophages may contribute to the skin injury.
Accumulating evidence indicates that the excessive
production of NO plays a pathogenic role in inflammation
(Nathan and Xie, 1994; Christopherson and Bredt, 1997;
Kubes, 2000). NO is a free radical produced from L-arginine
by three distinct enzymes. Among those enzymes, iNOS is
not normally detected in tissues, but its expression is induced
in inflammatory conditions. The expression of iNOS in
various cells, including endothelium, epithelium, and in-
flammatory cells, is induced by proinflammatory cytokines
and lipopolysaccharide, and produces significant amounts of
NO for extended periods of time (Nathan and Xie, 1994).
iNOS has been shown to have multiple biological effects.
Although small amounts of iNOS are essential for normal
healing in the skin and intestinal mucosa (Kubes, 2000),
excessive iNOS can contribute to IR tissue injury via
promoting over production of NO from endothelial cells
(Kubes, 2000; Furuichi et al., 2003; Reid et al., 2004;
Hayasaki et al., 2006). In fact, iNOS/ mice exhibit reduced
IR injury in multiple organs (Ling et al., 1999; Suzuki et al.,
2000; Qi et al., 2004). In this study, infiltrating cells and
proinflammatory cytokine expression were reduced at day 3
(after the third IR cycle) compared to day 2 (Figures 1b–e and
3b). By contrast, iNOS expression appeared to be cycle-
responsive, since a consistent daily progression was seen
(Figure 3a). Since the number of IR cycles is critical for skin
tissue injury (Peirce et al., 2000), iNOS expression may
strongly associate with the extent of IR-induced skin injury.
Since iNOS is produced by various cells including macro-
phages stimulated with proinflammatory cytokines (Nathan
and Xie, 1994), macrophage infiltration and proinflammatory
cytokine expression may cooperatively contribute to the
subsequent iNOS expression during IR cycles. These findings
suggest that the macrophage is an important mediator for the
induction of IR injury and strategies that inhibit initial
macrophage infiltration or activation may be useful in the
treatment of pressure ulcers.
As far as we know, investigation of IR skin injury has not
been reported in any transgenic mice, probably due to the
lack of an established mouse model. Our results using the
murine model proposed by Stadler et al. (2004) in wild-type
mice suggest that MCP-1, a prototype chemotactic factor for
macrophages, played an important role in cutaneous IR-
induced injury. Specifically, protein levels of MCP-1 were
found to peak early at day 1 (Figure 3c), followed by
inflammatory cell infiltration, which peaked at day 2 (Figures
1d and e). Additionally, recent studies have demonstrated
that the MCP-1/CCR2 pathway has important roles for IR
injury via recruiting macrophages and subsequent production
of cytokines and iNOS in some organs including myocardium
and kidney (Furuichi et al., 2003; Hayasaki et al., 2006).
Therefore, we examined the role of MCP-1 in pressure ulcer
formation by generating a cutaneous IR injury using MCP-1/
mice. The loss of MCP-1 significantly reduced the infiltration
of macrophages but not neutrophils (Figure 4e), consistent
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with its critical role for the recruitment of macrophages.
Furthermore, MCP-1 deficiency significantly inhibited the
expression of TNF-a and iNOS during IR cycles (Figure 6a).
Unfortunately, it was difficult to quantitatively evaluate the
severity of tissue injury during IR cycles in this model.
However, wound healing may be accelerated or delayed
depending on the prior tissue injury. As expected, wound
repair was accelerated and the ulcers were completely
healed 4 days earlier in all MCP-1/ mice compared to
wild-type mice (Figures 5e and f). Since the repair of
incisional skin wounds was rather delayed by the loss of
MCP-1 as previously reported (data not shown and Low et al.,
2001), this further supports the finding of milder cutaneous IR
injury in MCP-1/ mice. Additionally, continuous 36-hour
ischemia treatment developed skin ulcer that healed earlier
than treatment with IR cycles, in spite of the same period of
ischemia in wild-type mice (Figures 5h and i). By contrast,
both 36-hour ischemia and IR cycles showed similar skin
injury in MCP-1/ mice (Figures 5h and i). These findings
suggest that MCP-1 has important roles in IR-induced skin
injury via recruiting macrophages and subsequent production
of TNF-a or iNOS, especially during the reperfusion process.
MCP-1 may also play a role in IR injury through the activation
of CCR2-expressing macrophages, as demonstrated in renal
IR injury (Furuichi et al., 2003). Furthermore, MCP-1 has
been demonstrated to induce the release of lysosomal
enzymes and the generation of iNOS and superoxide anions,
resulting in tissue destruction (Baggiolini et al., 1994; Ikeda
et al., 1994; Christopherson and Bredt, 1997). Thus, the
interaction between MCP-1 and CCR2 may be critical for the
generation of cutaneous IR injury.
Most therapeutic investigations of pressure ulcer formation
have been performed using incision skin wounding. How-
ever, an incision wound healing model cannot clarify the
mechanism of pressure ulcer development and thus may not
identify important molecules for therapeutic targeting.
Furthermore, the course of wound healing of incision skin
may be different from IR-induced skin ulcer or pressure ulcer.
MCP-1/ mice demonstrate delayed healing of incision skin
wounds compared with wild-type mice (data not shown and
Low et al., 2001). However, the IR-induced skin ulcer was
healed earlier in MCP-1/ mice than in wild-type mice,
likely as a result of suppressed IR-skin injury in this model
(Figures 5a–e). Similarly, wild-type mice treated with an iNOS
inhibitor and iNOS/mice show delayed healing of cutaneous
excisional wounds despite the critical role of iNOS for
developing IR injury (Yamasaki et al., 1998). Therefore, a
cutaneous IR injury model is more appropriate for the
investigation of wound healing in pressure ulcers than an
incision wound-healing model. Thus, this mouse model may be
useful for investigating the mechanism or therapeutic strategy of
both IR injury and wound healing in pressure ulcers.
In the current study, apoptosis was significantly increased
cycle dependently during IR cycles (Figures 7a and b).
Furthermore, reperfusion rather than the ischemic period was
critical for the induction of apoptosis (Figure 7c). This is
consistent with an experimental IR model of myocardium
(Eefting et al., 2004). Interestingly, apoptosis was inhibited by
the loss of MCP-1 (Figures 7a and b). Furthermore, our
findings indicate that MCP-1 has a role in apoptosis induction
during reperfusion rather than ischemia (Figure 7c). Increas-
ing evidence has demonstrated that cytoprotective genes
such as HIF-1a and several HSPs can protect organs from IR-
induced apoptosis (Marber et al., 1995; Plumier et al., 1995).
A previous rat model of skin IR injury demonstrated that
genes with cytoprotective effects are initially upregulated
during the first cycle, but their upregulation was subsequently
reduced during the second cycle (Sisco et al., 2007). These
findings may explain the cycle-dependent development of
skin injury. However, in this study, expression levels of
cytoprotective genes such as HIF-1a and HSP90 were not
significantly changed during IR cycles (Figure 6c). Further-
more, these expression levels were not significantly changed
by the loss of MCP-1 (Figure 6c). Therefore, cycle-dependent
apoptosis or reduced apoptosis by MCP-1 deficiency is not
due to changes in the expression levels of these cytoprotec-
tive genes. Although the effect of NO on apoptosis is
complex, it is generally accepted that high concentration of
NO induces apoptosis (Lipton et al., 1993; Schulz et al.,
2004). In our experiments, iNOS expression was significantly
increased by IR cycles (Figure 3a). Additionally, the
augmented iNOS expression was remarkably reduced by
the loss of MCP-1 (Figure 6a). Furthermore, blocking of iNOS
expression significantly reduced the apoptosis during the
reperfusion process of IR cycles in wild type but not MCP-1/
mice (Figure 7c). Taken together, these observations suggest
that MCP-1 has a role in iNOS expression and subsequent
apoptosis and skin injury during the reperfusion process of IR
cycles.
Despite the absence of MCP-1, skin inflammation and
ulcer formation were not completely inhibited (Figures 4 and 5).
Although MCP-1 is the central chemokine for recruiting
macrophages, other chemokines, including fractalkine, MIP-1a,
and MCPs 2–4, also contribute to the chemotaxis of
macrophages. Therefore, other chemokines may compensate
for the role of MCP-1 to some extent in this model.
Additionally, MCP-1-independent mechanisms likely exist.
For example, neutrophil infiltration was independent of MCP-
1 in this model (Figure 4e), although several studies have
reported that the interaction between MCP-1 and CCR2
promotes the chemotaxis of neutrophils during inflammation
(Tessier et al., 1996; Johnston et al., 1999). Since the
expression of KC, a CXC chemokine, was increased during
IR cycles in wild-type mice (Figure 3c), CXC chemokines,
including KC, may also have a role in IR-induced skin injury
via recruiting neutrophils. Future studies using transgenic
mice will be needed to clarify the role of various chemokines,
cytokines, or adhesion molecules in IR-induced skin injury.
Applications of this model on the vast number of transgenic
mice will be beneficial to extend our understanding of the
mechanism of pressure ulcer development.
MATERIALS AND METHODS
Animals
C57BL/6 wild-type and MCP-1/ mice (C57BL/6 background; Lu
et al., 1998) were obtained from The Jackson Laboratory (Bar
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Harbor, ME). All mice were healthy, fertile, and did not display any
evidence of infection or disease. Female mice (8- to 12-week-old)
were used for all the experiments. All mice were housed in specific
pathogen-free barrier facility and screened regularly for pathogens.
All mice were individually housed in stainless cages to prevent
accidental dislocation of the magnets and to prevent tampering with
the resultant ulcer by other mice. All studies and procedures were
approved by the Committee on Animal Experimentation of
Kanazawa University Graduate School of Medical Science.
IR cycles
The IR cycle model that has been previously reported was used
(Stadler et al., 2004). Briefly, mice were anesthetized with diethyl
ether and their backs were shaved and cleaned with 70% alcohol. A
template was used to mark the location of the magnetic plates to
assure a consistent placement on each mouse. It has been
demonstrated that an external pressure of 50mmHg is sufficient to
induce IR skin necrosis by reducing blood flow by 80% (Peirce et al.,
2000). The skin was gently pulled up and placed between two round
ceramic magnetic plates that had a 12-mm diameter (113mm2) and
were 5mm thick, with an average weight of 2.4 g and 1,000G
magnetic forces (Seiko Sangyo Co., Ichikawa, Japan). Epidermis,
dermis, subcutaneous fat layer, panniculus carnosus, and subcuta-
neous loose connective tissue layer (hypodermis), but not muscles,
were pinched with the magnet plates. This process created a
compressive pressure of 50mmHg between the two magnets (Peirce
et al., 2000; Stadler et al., 2004). Three IR cycles were performed in
each mouse to initiate decubitus ulcer formation. A single IR cycle
consisted of a 12-hour period of magnet placement, followed by a
release or rest period of 12 hours. Mice were not immobilized,
anesthetized, or otherwise treated during IR cycles. All of the mice
developed two circular ulcers separated by a bridge of normal skin,
as reported previously (Stadler et al., 2004). For analysis, mice were
anesthetized and the areas of the skin ulcer were measured by
tracing the wound openings onto a transparency. The mean area of
the two skin ulcers was defined as the size of the skin ulcer in each
mouse. Skin tissues during or after IR cycles were harvested and
were used for subsequent analysis. In some experiments, a single
treatment of 36-hour ischemia by magnet placement was performed
instead of IR cycles.
Histological examination and immunohistochemistry
After the mice were killed, wounds were harvested with a 2-mm rim
of unwounded skin tissue. The wounds were cut into laterally halves,
fixed in 3.5% paraformaldehyde, and embedded in paraffin. Sections
(6mm) were stained with hematoxylin and eosin or processed for
immunostaining. For immunohistochemistry, deparaffinized sections
were treated with endogenous peroxidase-blocking reagent (DAKO
Cytomation A/S, Copenhagen, Denmark) and proteinase K (DAKO
Cytomation A/S) for 6minutes at room temperature. Sections were
then incubated with rat mAbs specific for macrophages (clone F4/80;
American Type Culture Collection, Rockville, MD), rabbit anti-
myeloperoxidase polyclonal antibody (Neomarkers, Fremont, CA),
or rat anti-mouse CD3 mAb (Dainippon Pharmaceutical Company,
Osaka, Japan). Rat IgG (Southern Biotechnology Associates Inc.,
Birmingham, AL) was used as a control for nonspecific staining.
Sections were then incubated sequentially (20minutes, 37 1C) with a
biotinylated rabbit anti-rat IgG secondary antibody (Vectastain ABC
method; Vector Laboratories, Burlingame, CA) or a biotinylated goat
anti-rabbit IgG secondary antibody (BD Biosciences, San Jose, CA),
and then with horseradish peroxidase-conjugated avidin–biotin
complexes. Sections were washed three times with phosphate-
buffered saline between incubations. Sections were developed with
3,3’-diaminobenzidine tetrahydrochloride and hydrogen peroxide,
and then counterstained with methyl green. The number of
neutrophils, macrophages, and T lymphocytes determined with
immunostaining was counted and averaged in eight high-power
microscopic fields (HPFs, 0.07mm2) of five serial sections. The
number of mice used for each time point of examination was more
than 6 in each genotype.
Real-time RT-PCR
Total RNAs were extracted from injured skin samples using QIAGEN
RNeasy spin columns (QIAGEN Ltd., Crawley, UK) and digested with
DNase I (QIAGEN Ltd.) to remove chromosomal DNA in accordance
with the manufacturer’s protocols. Total RNA was reverse transcribed
to cDNA using a Reverse Transcription System with random
hexamers (Promega, Madison, WI). Real-time RT-PCR was performed
using the TaqMan system (Applied Biosystems, Foster City, CA) on an
ABI Prism 7000 Sequence Detector (Applied Biosystems) according
to the manufacturer’s instructions. TaqMan probes and primers for
iNOS, TNF-a, IFN-g, IL-1b, IL-6, HIF-1a, HSP90, and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) were purchased from
Applied Biosystems. Relative expression of real-time PCR products
was determined using the DDCt technique. Briefly, each set of
samples was normalized using the difference in threshold cycle
(Ct) between the target gene and housekeeping gene: DCt¼
(Ct target gene Ct GAPDH). Relative mRNA levels were calculated
by the expression 2DDCt , where DDCt¼DCt sampleDCt calibrator.
Each reaction was performed in, at least, triplicate. The number of
mice used for each time point of examination was more than six in
each genotype.
ELISA
Wound tissues were homogenized with 0.3ml of lysis buffer (10mM
phosphate-buffered saline, 0.1% SDS, 1% Nonidet P-40, and 5mM
EDTA) containing Complete Protease Inhibitor mixture (Roche
Diagnostics, Tokyo, Japan), as described previously (Mori et al.,
2002). The homogenates were centrifuged at 12,000 r.p.m. for
15minutes, with the supernatants being analyzed by ELISA. Protein
levels of MCP-1, MIP-1a, KC, fractalkine, and TNF-a in tissue extract
or serum were measured with commercial ELISA kits (R&D Systems
Inc., Minneapolis, MN), according to the manufacturers’ recom-
mendation, and the color intensity was measured at 450 nm. The
detection limits for each chemokine were as follows: MCP-1,
15.6 pgml1; MIP-1a, 4.7 pgml1; KC, 15.6 pgml1; fractalkine,
0.62 ngml1; TNF-a, 11.7 pgml1. Total protein in the supernatant
was measured with a commercial kit (BCA Protein Assay kit; Pierce,
Rockford, IL). The data were expressed as chemokine (pgml1 or
ngml1)/total protein (mgml1) for each sample. The number of
mice used for each time point of examination was more than six in
each genotype.
Detection of apoptosis
To localize and assess apoptotic cells, a TUNEL kit (DermaTACS;
R&D Systems Inc.) was used. The TUNEL assay was performed
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according to the protocol supplied by the manufacturer. The number
of fibroblastic apoptotic cells was determined by counting the
number of TUNEL-positive cells that had the characteristic micro-
scopic appearance of fibroblasts. Two independent observers
unaware of either treatment or genotype assessed the number of
apoptotic cells present in 12 HPFs (0.07mm2) of 10 serial sections,
with the average results being shown. The studied region (hypo-
dermis) was standardized between skin slices.
Selective inhibition of iNOS activity
In some experiments, we used an inhibitor of iNOS activity, 1400W
(BIOMOL Research Laboratories Inc., Plymouth Meeting, PA)
(Garvey et al., 1997). Mice underwent the same procedure of IR
cycles or 36-hour ischemia, but were also treated with 1400W
(10mg kg1, intravenous) administered 5minutes before and each
24 hours during the procedure.
Statistical analysis
The Mann–Whitney U-test was used to determine the level of
significance of differences between the sample means, and
Bonferroni test was used for multiple comparisons. A P-value
o0.05 was considered statistically significant.
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